J. M. Joulia

Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid.

J. M. Joulia, F. Pinguet, M. Ychou, 1999, European journal of cancer.

Methyl-beta-cyclodextrin and doxorubicin pharmacokinetics and tissue concentrations following bolus injection of these drugs alone or together in the rabbit.

J. M. Joulia, F. Pinguet, F. Bressolle, 1999, International journal of pharmaceutics.

High-performance liquid chromatographic assay for methyl-beta-cyclodextrin in plasma and cell lysate.

J. M. Joulia, F. Pinguet, C. Astre, 1997, Journal of chromatography. B, Biomedical sciences and applications.

Determination of 5-fluorouracil and its main metabolites in plasma by high-performance liquid chromatography: application to a pharmacokinetic study.

J. M. Joulia, F. Pinguet, C. Astre, 1997, Journal of chromatography. B, Biomedical sciences and applications.

High-performance liquid chromatographic assay for melphalan in human plasma. Application to pharmacokinetic studies.

J. M. Joulia, F. Pinguet, C. Astre, 1996, Journal of chromatography. B, Biomedical applications.

Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer

J. M. Joulia, F. Pinguet, M. Ychou, 1999, Cancer Chemotherapy and Pharmacology.

Individual 5FU-dose adaptation schedule using bimonthly pharmacokinetically modulated LV5FU2 regimen: a feasibility study in patients with advanced colorectal cancer.

J. M. Joulia, F. Pinguet, M. Ychou, 1999, Anticancer Research.

Pharmacokinetics of 5-fluorouracil (5-FUra) in patients with metastatic colorectal cancer receiving 5-FUra bolus plus continuous infusion with high dose folinic acid (LV5FU2).

J. M. Joulia, F. Pinguet, M. Ychou, 1997, Anticancer research.